⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL802642 | 0.84 | — | — | |
| SCHEMBL15478046 | 0.84 | — | — | |
| SCHEMBL802625 | 0.78 | TK1 (0.34) | — | |
| SCHEMBL22984030 | 0.72 | — | — | |
| SCHEMBL802971 | 0.71 | STING1 (0.39) | — | |
| SCHEMBL15478065 | 0.71 | PI4KA (0.39) | — | |
| SCHEMBL803169 | 0.71 | NT5E (0.33) | — | |
| SCHEMBL803186 | 0.71 | — | — | |
| SCHEMBL15478071 | 0.71 | — | — | |
| SCHEMBL22518665 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8653254-B2 | Process for producing nucleoside | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20120071646-A1 | PROCESS FOR PRODUCING NUCLEOSIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-22 | — | — | US | disclosed |